1C0 fundamentals
An in-depth look to CELYAD ONCOLOGY S.A. operating, investing, and financing activities
1C0 free cash flow for H2 23 is -7.45 M EUR. For 2023, 1C0 free cash flow was -16.1 M EUR and operating cash flow was -15.2 M EUR.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
TTM